Publicacións en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (42)

2025

  1. Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia

    Computers in Biology and Medicine, Vol. 188

2024

  1. ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

    Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2351-2359

  2. Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético)

    Transplantation and Cellular Therapy, Vol. 30, Núm. 10, pp. 1015.e1-1015.e13

  3. Identification of copy-number variants in patients with overgrowth disorders

    Clinical Genetics, Vol. 106, Núm. 5, pp. 614-624

  4. Other Genodermatoses

    Dermatology: Volume 1-2, Fifth Edition (Elsevier), pp. 1035-1066

  5. Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee

    Cytotherapy

2023

  1. Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment

    Journal of Clinical Medicine, Vol. 12, Núm. 15

  2. Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure

    Transplantation and Cellular Therapy, Vol. 29, Núm. 10, pp. 621.e1-621.e6

  3. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

    Frontiers in Pediatrics, Vol. 11

  4. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

  5. TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia

    Haematologica

  6. The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)

    Frontiers in Pediatrics, Vol. 11

  7. Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

    Transplantation and Cellular Therapy, Vol. 29, Núm. 11, pp. 702.e1-702.e11

2022

  1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

  2. Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)

    Medicina Clinica, Vol. 159, Núm. 9, pp. 411-419

  3. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

2021

  1. Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia

    Clinical and Translational Oncology

  2. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

  3. Matched sibling donor stem cell transplantation for sickle cell disease: Results from the Spanish group for bone marrow transplantation in children

    European Journal of Haematology, Vol. 106, Núm. 3, pp. 408-416

2020

  1. Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP)

    British Journal of Haematology, Vol. 190, Núm. 5, pp. 764-771